Rimos Hyperoil Oily Formulation Dropping bottle 50ml - multi-functional and self-sufficient wound dressing

By buying this product you can collect up to 3 loyalty points. Your cart will total 3 points that can be converted into a voucher of 0,75 €.

Preview the shipping fees

Please select your country and state (if not available please contact us immediately at info@zachospharmacy.gr)

Zachos Pharmacy

38,89 €

33,45 € Product Id: 3377



Not available for order



Rimos Hyperoil Oily Formulation Dropping bottle 50ml - multi-functional and self-sufficient wound dressing

More details

Content (ml)50

Wound care treatment using a single product is possible thanks to Hyperoil®: advanced, multi-functional and self-sufficient wound dressing.

Multi-functional because suitable for lesions of any type and nature.

Self-sufficient, preventing the aid of disinfectants.

Hyperoil® is not a drug and doesn't need any medical prescription.
It was registered as Class IIb Medical Device.
Reg. No: MED 27033 - Notified Body EC no.0476.
CE certification has been obtained thanks to
the clinical trials presented
about biocompatibility tests and risk analysis,
which showed that Hyperoil® is reliable and EFFECTIVE,
without side effects nor contraindications.


Hyperoil® is Multifunctional because:
• it effectively promotes skin wound healing process related to
different kind of diseases and disorders
• it can be used in at every stage/grade of a wound.
Hyperoil® is Self-sufficient because:
• it has a wide range of properties so as not to require any other
primary dressing during treatment.
Hyperoil® has a VEGETAL origin and is based upon the combination
of oily extracts derived from two plants:
• Neem tree (Azadirachta Indica A. Juss)
• Hypericum or St. John's Wort (Hypericum Perforatum L.)
Their extraordinary therapeutic properties are known for centuries.
The scientific and technological research has succeeded
in extracting two basic active principles from these two plants,
among hundreds of their components:
Azadirachtin and Hyperforin.

The Class IIb CE-certified Medical Devices Act does not require to demonstrate which of these components is responsible for the product effectiveness.
Anyway for each product batch, it is mandatory to check the percentages of the two essential active ingredients, which must be kept at the same level of those used in the clinical trials.
This certification allows to commercialise the product within the European Community.
In Italy, the product is commercialised under the same CE Certification (no. 0476) but with a different name and patent: Holoil®

No customer comments for the moment.

Write a review

Write a review

products in the same category: